Abstract:Inactivation of tumor suppressor p53 is one of the most frequent events in cancer. Unlike many other cancers, however, p53 gene mutations are infrequent in breast cancers, as about 80% of breast tumors contain wild type p53. The mechanisms underlying functional inactivation of wild type p53 in breast cancer have remained elusive. Besides, how p53 gets activated in breast tumors subjected to radiation therapy remains unknown. We recently reported that in MCF-7 breast cancer cells, estrogen receptor alpha (ERα) directly binds to p53 and represses its function. Furthermore, the ERα-p53 interaction was disrupted by ionizing radiation. These observations have important translational implications especially as there are no reliable cellular or molecular criteria for rational radiotherapy for breast cancer. Here we report our studies towards addressing this important issue, using an MCF-7 breast cancer xenograft model in mice. Radiation effectively inhibits growth of these tumors and stabilizes p53, but has no observable effect on ERα protein level. Importantly, chromatin immunoprecipitation (ChIP) assays demonstrated that ERα interacts with p53 bound to endogenous target gene promoters in tumors in vivo, and this interaction is considerably reduced in response to radiotherapy although p53 level is increased. Concomitant with its effect on ERα-p53 interaction, radiation increases p53-mediated transcriptional activation of several target genes and increases p53-mediated transcriptional repression of survivin. Our studies show that disruption of ERα-p53 interaction in vivo resulting in restoration of functional p53 is a cellular response to radiation. Radiation could be affecting ERα and/or p53 directly or it could be influencing other proteins associated with the ERα-p53 complex. To the best of our knowledge, this is the first report on analysis of DNA–protein–protein interaction occurring on endogenous gene promoters in vivo in breast tumor tissues. These findings suggest that alleviating the inhibitory effect of ERα on p53 could be one of the molecular mechanisms underlying activation of p53 by radiation in breast tumors, and therefore, could be exploited to develop more effective ways of combining radiation therapy with systemic therapies such as hormonal therapy and chemotherapy.

[The Effect of HER2/neu Overexpression on P53 Gene Expression, Cell Proliferation and Sensitivity to Gamma-Irradiation Via the PI3K/Akt Pathway in Breast Cancer Cell MCF7].

[Overexpression of HER2/neu Downregulates Wild P53 Protein Expression Via PI3K and Ras/Raf/MEK/ERK Pathways in Human Breast Cancer Cells].

Downregulation of Wild-Type P53 Protein by HER-2/neu Mediated PI3K Pathway Activation in Human Breast Cancer Cells: Its Effect on Cell Proliferation and Implication for Therapy

HER2 Protein Expression Level is Positively Associated with the Efficacy of Neoadjuvant Systemic Therapy in HER2-positive Breast Cancer

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

PI3K/AKT Inhibitor Influence on the Radiosensitivity of Breast Cancer Cells

[Effect of Wt P53 Gene Transfection on Sensitivity of Hyperthermia in C6 Glioma Cells].

HER2 Overexpression Reverses the Relative Resistance of EGFR-mutant H1975 Cell Line to Gefitinib.

Lower Beclin 1 Downregulates HER2 Expression to Enhance Tamoxifen Sensitivity and Predicts a Favorable Outcome for ER Positive Breast Cancer

Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.

Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy

HER2 Reduces Breast Cancer Radiosensitivity by Activating Focal Adhesion Kinase in Vitro and in Vivo

Effect of Adenovirus-mediated Wild-Type P53 Gene Transfection on the Growth and Radiosensitivity of Human Lung Adenocarcinoma Cells

Effect of Sirna Targeting HER2/neu on the Proliferation and Viability of Prostate Cancer PC-3M Cells.

Overexpression of EPDR1 has an antitumorigenic effect on breast cancer in vitro

BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway

Co-inhibition of Epidermal Growth Factor Receptor and Insulin-Like Growth Factor Receptor 1 Enhances Radiosensitivity in Human Breast Cancer Cells

HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration

Analysis and Validation of PI 3 K / AKT Signaling Pathway Associated with Overall Survival Time of Patients with HER 2-Positive Breast Cancer

P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells

Overexpression of P53 is prognostic for aromatase inhibitor resistance in early stage postmenopausal patients with ER-positive breast cancer